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Available online 18 April 2016Clinical diagnosis of leishmaniasis is highly complex, presenting a wide range of clinical man-
ifestations, sometimes non-speciﬁc, and thus the epidemiological study and diagnostic need
speciﬁc molecular markers for each Leishmania species. Leishmania spp. posses different Fe-
SOD isoforms, one of which is excreted into the external milieu and, presenting immunogenic
characteristics, is a very reliable molecular marker. Superoxide dismutases (SODs) are antioxi-
dant metal-enzymes responsible for the dismutation of superoxide ion into hydrogen peroxide
and molecular oxygen, and it is considered an important virulence factor. In this manuscript
we have puriﬁed the iron(Fe)-SOD excreted by Leishmania braziliensis using ion-exchange
and molecular-sieve chromatography and we have studied it as an antigen in serodiagnostic
analyses in ELISA and Western blot techniques, testing 213 human sera from Mexico. Indeed,
L. braziliensis Fe-SODe has been puriﬁed 123.26 times with a speciﬁc activity of about
893.66 U/mg of protein. Applying the puriﬁed enzymes in serological tests we found 17.84%
sera positive. We have demonstrated that the puriﬁed enzyme is more sensitive than the
non-puriﬁed ones and we also demonstrated, for the ﬁrst time, the presence of antibodies
against L. braziliensis, not the main species in the country, in human population from Hidalgo
and Nuevo Leon States.
© 2016 The Authors. Published by Elsevier Ltd on behalf of World Federation of Parasitologists.







According to WHO's ofﬁcial reports, leishmaniasis is endemic in 98 countries or territories, 12 million people are infected, 350
million are at risk, and 2 million new cases are reported every year, thus the infection represents a major public-health problem
(WHO, 2015; WHO, 2010). Leishmaniasis is the “third world” typical disease, characterized by rural transmission, localized in re-
mote areas in the urban hoods, where socio-economical and sanitarian conditions are poor and the disease is not diagnosed duey, Faculty of Science, University of Granada, 18071 Granada, Spain.
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the transmission areas, the level of population exposition to the parasite, and, particularly important, the human behaviour
(Parham et al., 2015). Depending on the Leishmania species infecting the vertebrate host it can present three different clinical
manifestations: cutaneous, mucocutaneous or visceral; all of them starting with the sandﬂy, the invertebrate vector, bite in
where the metacyclic promastigotes are injected (Cáceres and Montoya, 2002). Clinical diagnosis of this disease is very complicat-
ed; they present a wide range of clinical manifestations, sometimes not-speciﬁc, such as Leishmania peruviana and Leishmania
braziliensis; both start with a small cutaneous ulcers, but meanwhile for the ﬁrst species it is a self-healing sore (WHO, 2010),
in case of L. braziliensis infection, if not treated, it will develop to mucocutaneous leishmaniasis with a consequently very painful
and facial disﬁguration of the patient (de Vries et al., 2015; WHO, 2010). Indeed depending on each species a different kind of
treatment is needed.
In 1912 Seidelin reported the ﬁrst clinical case in Mexico of cutaneous leishmaniasis, called “gum picker's ulcer”(Seidelin,
1912) Since then, at least three clinical forms have been reported in this country: localized cutaneous, diffuse cutaneous and vis-
ceral leishmaniasis (Velasco-Castrejón, 1987). Previously, only three main endemic areas were known in Mexico: in the south-east
area from the south of the State of Veracruz to the States of Quitana Roo and Chiapas; in the north, in the States of Tamaulipas,
Nuevo Leon, Coahuilla, and San Luis de Potosi; and the third area, in the States of Puebla, Morelos, Oaxaca, and Michoacan, where
visceral leishmaniasis was endemic (Velasco-Castrejón, 1987). Currently, leishmaniasis has been reported in 22 states, including
Hidalgo and Nuevo Leon (Velasco-Castrejón et al., 2009; Monroy-Ostria and Sanchez-Tejeda, 2002). The main species of human
leishmaniasis throughout Mexico is Leishmania mexicana but different species have also been found in the country, including
L. braziliensis (Monroy-Ostria and Sanchez-Tejeda, 2002; Sanchez-Tejeda et al., 2001) and Leishmania infantum (syn. chagasi)
(WHO, 2010). There is no study about prevalence of L. braziliensis infection in human in Mexico and it is considered as minor spe-
cies, nonetheless 12 PCR positive patients have been reported in 2001 from the State of Nayarit in the north-west of the country
(Sanchez-Tejeda et al., 2001). In the south of Mexico, Canto-Lara et al. (1999) identiﬁed, using speciﬁc polyclonal antibodies, iso-
enzyme electrophoresis and molecular techniques the presence of a L. braziliensis infection in one human from the State of Cam-
peche. Furthermore, dogs and cats have been found to present antibodies against this species of Leishmania (Longoni et al., 2012;
Longoni et al., 2011). The recognition of the proper species of Leishmania is crucially important; on one hand, some cutaneous
leishmaniasis are self-healing and the treatment is not necessary, thus the correct pathogen identiﬁcation makes possible to re-
duce costs and avoid chemotherapy with serious side effects, while on the other hand timely treatment of mucocutaneous leish-
maniasis can save a patient from a very painful and disﬁguring course of the disease. Unfortunately, differential diagnosis of
leishmaniasis is still a major challenge, as current commercial kits are unable to distinguish among different Leishmania species,
which is an important goal in areas endemic for more than one species. Different molecules have been proposed as diagnostic
markers, but none of them proved successful. An iron superoxide dismutase excreted (Fe-SODe) by trypanosomatids has been
used in ELISA technique with good results in Phytomonas spp. (Marín et al., 2006) and Trypanosoma cruzi (Mateo et al., 2010).
Fe-SOD excreted by different Leishmania species has been used to diagnose cutaneous, mucocutaneous, and visceral leish-
maniasis in humans, dogs, and cats (Longoni et al., 2012; Longoni et al., 2011; Marín et al., 2009; Marín et al., 2007), showing
high sensitivity and speciﬁcity while lacking cross reactions with other trypanosomatids like T. cruzi (Marín et al., 2009).
In the present work, we have puriﬁed the Fe-SOD excreted by L. braziliensis (mucocutaneous leishmaniasis) and used it for
human leishmaniasis diagnostic. We tested 213 human sera from Mexican States of Hidalgo and Nuevo Leon. The main aim of
this work was to assess the sensitivity of this puriﬁed antigen in comparison respect the same protein not puriﬁed eliminating
all interference due by antigen sample preparation impurities. In addition, we report the presence of L. braziliensis Fe-SODe anti-
bodies in patients from areas where L. braziliensis infections in humans have never been found before.
2. Material & methods
2.1. Parasite culture
Promastigotes of L. braiziliensis (MHOM/BR/75/M2904) were grown in tissue-culture ﬂasks and an axenic medium trypano-
somes liquid (MTL) medium (Hank's Balanced Salt Solution—HBSS (Gibco®), CO3HNa, Lacto-albumin, yeast extract, bovine
haemoglobin and antibiotics), supplemented with 10% heat-inactivated foetal bovine serum (FBS) at 26 °C until reaching a pop-
ulation of approximately 1 × 107 parasites/mL. Cells were harvested at the logarithmic growth phase by centrifugation (1500 ×g
for 10 min at room temperature). The pellet of cells (0.5–0.6 g wet weight/mL) was suspended in 25 mL of MTL medium that had
not been enriched with foetal bovine serum (FBS) and cultured at 26 °C for 24 h.
2.2. Antigen preparation: extraction and puriﬁcation of Fe-SODe
After 24 h, the promastigote culture was centrifuged (1500 ×g for 10 min) and the supernatant was ﬁltered (Minisart®,Φ
20 μm). The ﬁltered supernatant was subjected to ice-cold ammonium sulphate precipitation at 35% salt concentration. Following
centrifugation, the resultant supernatant was then treated with 85% ice-cold ammonium sulphate and the second precipitate col-
lected. The resulting precipitate was ﬁnally dissolved in 2.5 mL of distilled water and desalted by chromatography in a Sephadex
G-25 column (GE Healthcare Life Sciences®, PD 10 column), previously equilibrated with 25 mL of distilled water, bringing it to a
ﬁnal volume of 3.5 mL (Fraction P85e or SODe-np-Lb). Degradation due to the activity of protease present in the sample was min-
imized by the adding 25 μL of protease inhibitor to the fraction P85e (CompleteMini, Roche®). Fraction P85e was introduced to a
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pH 7.4, containing 1 mM EDTA). The adsorbed proteins were eluted with a linear gradient of KCl (0–0.6 M). Fractions with a total
volume of 2.5 mL were recollected. Fractions exhibiting speciﬁc SOD activity were pooled (peak Q1e) and concentrated by ultra-
ﬁltration in Microcon® ﬁlter tubes (Amicon®) at 11,200 ×g for 30 min. The peak Q1e was introduced to a Sephadex G-100
(Sigma Immunochemicals®) molecular sieve chromatography column (75 × 1.6 cm Φ) equilibrated with Buffer 1 and eluted
with 200 mL of the same buffer. The eluted fractions (4.5 mL each fraction) which showed SOD activity were again collected
(peak SODe-Lb), concentrated (to 2 mg/mL) and used for the assays as described below.
2.3. Protein determination
The protein content of the fractions P85e and the peaks Q1 and SODe-Lb, and all the fractions resulting from the elution of the
two columns were quantiﬁed using the Sigma Bradford test, which uses BSA as a standard (no traceability was certiﬁed for the
BSA standard) (Bradford, 1976).
2.4. Spectrophotometric enzyme assays
SOD activity was measured on the fraction P85e, the peaks Q1 and SODe-Lb and all the fractions eluted by spectrophotometric
measurement of NBT-UV light oxidation as previously described by Beyer and Fridovich (1987).
2.5. Determination of the molecular weight
Apparent molecular weight was calculated using the equation (y = −0.952 × +118.51) obtained from the linear trend line
generated from the graph of chromatography standards (Bovine Serum Albumine, 67 kDa; Albumin from chicken egg white,
45 kDa; carbonic anhydrase, 30 kDa; and cytochrome C, 12.4 kDa; all from Sigma Immunochemicals, St. Louis) (Microsoft
Excel®, 2007). Molecular weight was conﬁrmed by testing the SODe-Lb fractions with native gel electrophoresis in PhastGel Ho-
mogeneous 12.5% as described in the Phast System manual (GE Healthcare Life Sciences®). Molecular weights of standard pro-
teins were: phosphorylase B (94 kDa), bovine serum albumin (67 kDa), ovalbumin (43 kDa), carbonic anhydrase (30 kDa),
soybean trypsin inhibitor (20.1 kDa) and α-lactalbumin (14.4 kDa), all from LMW (GE Healthcare Life Sciences®). The gels
were stained for protein with high-sensitivity 0.5% silver nitrate staining according to the Phast System manual (GE Healthcare
Life Sciences®).
2.6. Isoelectric point determination
Isoelectro focusing (IEF) in polyacrylamide Phast Gel 3–9 (GE Healthcare Life Sciences®) enabled us to determine the isoelec-
tric points of the puriﬁed enzymes, using trypsinogen (9.3), lentil-lectin acidic band (8.8), horse-heart myoglobin (6.8), soybean
trypsin inhibitor (4.6) and amyloglucosidase from Aspergillus niger (3.6) as markers (Longoni et al., 2013). The gels were stained
with the silver-nitrate solution for proteins and using the Beyer and Fridovich's (1987) method, in which enzyme activity appears
as a chromatic band on a blue background.
2.7. Serological test (ELISA)
The antigenic fractions: SODe-np-Lb (corresponding to fraction P85), and the puriﬁed SODe-Lb, at a total concentration of
1.5 μg and, 0.5 μg and 0.05 μg, respectively, were used to sensitize polyethylene microtitre plates (Nunc, Dermark) in carbonate
buffer (pH 8.2) for 2 h at 37 °C. Antigens not ﬁxed in the plate were eliminated and washed 3 times with phosphate buffered
saline (PBS), Tween 20® 0.05% (wash buffer). Free absorption sites where the antigen did not come together were blocked for
2 h (37 °C) using a blocking solution (PBS-Tween 20® at 0.2%, bovine serum albumin at 1%). After washing as before, the
plate was incubated for 45 min in the presence of human serum at a 1:200 dilution. After a further washing it was again incu-
bated for 30 min (37 °C) with immunoconjugate (anti-IgG with anti-human peroxidase, Sigma Immunochemicals®), at a dilution
of 1:1000. The enzymatic, chromogenic reaction was performed for 20 min in darkness on an OPD substrate (Phenylenediamine
dihydrochloride, Sigma Immunochemicals®) using 10 μL of 30% H2O2 for each 25 mL. The reaction was blocked by adding 50 μL of
3 N HCl. Absorbance was read at 492 nm using a microplate reader (SunriseTM, TECAN). All samples were analysed in triplicate in
microtitre plates. The mean and standard deviation (SD) of the optical density of negative-control sera (4 healthy humans) were
utilized to calculate the cut-off value (mean + 3 × SD).
2.8. Western blot analysis
The SODe-Lb antigen fractions (total concentrations of 0.5 μg of protein) were merged into IEF 3–9 gels and subsequently
transferred to nitrocellulose for 30 min, as described in the Phast System manual. The membrane was blocked for 2 h at room
temperature using 0.4% gelatine and 0.2% Tween 20 in PBS, followed by three washes in 0.1% Tween 20 in PBS (PBS-T) and incu-
bated for 2 h at room temperature with human sera at a dilution of 1:200. After a second washing, the membrane was incubated
for two more hours at room temperature with the second antibody, anti-human immunoglobulin G conjugate with peroxidase
Fig. 1. Puriﬁcation proﬁles of SOD excreted from Leishmania braziliensis. (A) QAE A-50 ion exchange chromatography. ( ): protein concentration; ( ):
SOD activity; ( ): gradient 0–0.6 M KCl. (B) Sephadex G-100 sieve chromatography. ( ): protein concentration; ( ): SOD activity.
(C) Isoelectric focusing gel electrophoresis pI 3–9 of the fractions eluted by Sephadex G-100, the SOD activity was stained following the Beyer and Fridovich's
(1987) protocol.
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Tris/HCL 0.1 M, pH 7.4 containing 1/5000 H2O2 [10 v/v]) and then added to the reaction, which was stopped with a series of
washes with distilled water.
2.9. Human sera
The sera from a total of 213 patients were obtained between 2011 and 2012 from Hidalgo (81) and Nuevo Leon (132) States,
Mexico. All 213 patients were not infected with any Leishmania sp. at the time of the blood taking. Complete history is not
Table 1
Leishmania braziliensis excreted superoxide dismutase puriﬁcation summary.
Fraction Total protein (mg) Total activitya (Units) ± SD Speciﬁc activitya (U/mg ± SD) Puriﬁcation Yield (%)
P85 34.71 663.31 ± 9.98a 7.25 ± 4.41a 1 100
Peak Q1 1.106 631.59 ± 5.05a 322.49 ± 7.89a 44.48 95
SODe-Lb 0.442 395.00 ± 0.00 893.66 ± 0.00 123.26 60
“SD” is the standard deviation of the mean of four determinations.
a SOD activity determined by the technique of Beyer and Fridovich, (1987).
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tained from human sera put down by the Blood Bank in Granada (Spain) and were not reactive to in the serological tests.
Informed consent was obtained individually from all participants before the collection of blood samples.2.10. Ethics
This study was approved by the Ethics Committee (CEIH) of the University of Granada (Spain) in accordance with the Helsinki
Declaration of 1975, revised in 1983.3. Results
The supernatant recovered from the 24 h culture of 1 × 107 cells/mL in “FBS free MTL medium” was centrifuged, ﬁltered and
subjected to two ice-cold ammonium sulphate additions, to obtain a precipitate (SODe-np-Lb).
L. braziliensis SODe-np-Lb (total proteins amount 34.71 mg) was applied to a QAE-Sephadex A-50 ion exchange chromatogra-
phy column. Protein concentration and Fe-SOD activity were quantiﬁed in all the fractions eluted using the Bradford and the
Beyer and Fridovich methods, respectively, revealing only one active peak marked as Q1e (fractions 20–30) as shown in Fig. 1-
A. IEF 3–9 polyacrylamide gel electrophoresis of the fractions eluted from QAE-Sephadex A-50 columns was also performed to vi-
sualize the SOD activity (data not shown).Fig. 2. Electophoresis proﬁle of fraction p85 (Lines 1 and 3) and puriﬁed protein SODe-Lb (Lines 2 and 4). A: native gel electrophoresis in PhasGel homogeneous
12.5% stained following the manufacturer silver nitrate protocol. B: Isoelectro focusing (IEF) in polyacrylamide Phast Gel 3–9 stained following the Beyer and
Frodovich SOD activity protocol (Beyer and Fridovich, 1987).
Fig. 3. Immunoblot of the ELISA positive serum samples at a dilution of 1/200 against SODe-Lb. Lines 4–132 correspond to sera from Monterrey (Nuevo Leon State)
and Lines 3p, 13p and 28p correspond to sera from Pachuca (Hidalgo State). Line M: SODe activity in isoelectric focusing and staining following the technique of
Beyer and Fridovich (1987).
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protein and then applied to a Sephadex G-100 molecular sieve chromatography column. Protein concentration and SOD activity
were quantiﬁed in all fractions eluted as shown in Fig. 1-B. We obtained only one protein peak with SOD activity (fractions
21–27). IEF 3–9 polyacrylamide gel electrophoresis of the fractions eluted from Sephadex G-100 column was also performed to
visualize the SOD activity (Fig. 1-C).
The SODe-Lb peak obtained by molecular-sieve chromatography (fractions 21–27) was desalted and concentrated. Table 1
summarizes the puriﬁcation, indicating that SODe-Lb was puriﬁed approximately 123 times to a speciﬁc activity of about
894 U/mg of protein (Table 1). Differences between puriﬁed and not puriﬁed proteins are shown in Fig. 2.
The SODe-Lb molecular weight (MW) was determinate by native homogeneous 12.5% electrophoresis analysis, revealing only
one band of about 25 kDa. In the same way, the SODe-Lb isoelectric point (pI) was determined using an IEF 3–9 polyacrylamide
gel, showing a single activity band with a pI of about 3.75 (data not shown).
With the aim of demonstrating that the puriﬁed Fe-SOD excreted by L. braziliensis may be a suitable molecular tool for cuta-
neous human leishmaniasis diagnosis, 213 human sera from Mexico (81 from Pachuca city, Hidalgo State and 132 from Monterrey
City, Nuevo Leon State) were assayed by ELISA and Western blot techniques at a dilution of 1/200, using as antigens the non-
puriﬁed Fe-SODe (SODe-np-Lb) and puriﬁed Fe-SODe (SODe-Lb) (Fig. 3).
Using as antigen the SODe-np-Lb by ELISA technique, a total of 61 sera were positive (29.57%), 50 from Monterrey and 11
from Pachuca. When the SODe-Lb was used as an antigen, only 38 sera were positive (17.84%), 35 from Monterrey and 3 from
Pachuca (Table 2).Table 2
Relationship of positive sera fromMonterrey (Nuevo Leon State) and Pachuca (Hidalgo State) to L. braziliensisbyELISA (ELISA) andWestern blot (WB). Antigen fraction:
iron superoxide dismutase excreted not puriﬁed (Np), and iron superoxide dismutase excreted puriﬁed (P).
ELISA WB ELISA WB ELISA WB ELISA WB
Sera Np P P Sera Np P P Sera Np P P Sera Np P P
1.5a 0.5a 0.05a 0.5a 1.5a 0.5a 0.05a 0.5a 1.5a 0.5a 0.05a 0.5a 1.5a 0.5a 0.05a 0.5a
Monterrey (Nuevo Leon State)
2 + − − − 24 − + + + 57 + − − − 82 + − − −
3 + − − − 25 − + + + 60 + − − − 83 + − − −
4 + + + + 26 + + + + 61 + − − − 84 + + + +
5 + + + + 27 − + + + 62 + − − − 85 − + + +
6 − + + + 28 + + + + 63 + + + + 87 + + + +
7 + + + + 29 + − − − 64 + − − − 89 + − − −
8 − + + + 30 + − − − 65 + − − − 90 + − − −
9 + + + + 32 + − − − 66 + − − − 91 + − − −
10 + + + + 33 + − − − 67 + − − − 114 − + + +
11 + + + + 36 + − − − 70 + − − − 117 − + + +
12 − + + + 38 + − − − 71 + − − − 120 − + + +
18 − + + + 41 + − − − 74 + − − − 121 − + + +
19 + + + + 42 + − − − 75 + + + + 124 − + + +
20 + + + + 45 + − − − 76 + − − − 125 − + + +
21 + + + + 46 + − − − 78 + − − − 130 − + + +
22 − + + + 53 + + + + 80 + − − − 131 − + + +
23 + + + + 54 + − − − 81 + − − − 132 − + + +
Pachuca (Hidalgo State)
2 + − − − 15 + − − − 28 − + + + 45 + − − −
3 + + + + 16 + − − − 35 + − − − 64 + − − −
13 + + + + 26 + − − − 41 + − − − 65 + − − −
a μg/well used of each antigen fraction.
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technique. When we used the puriﬁed protein (SODe-Lb) as antigen the same results were revealed by testing the sera with
the Western blot technique, giving a 100% correspondence between the two techniques (Table 2).
Western blot results (Fig. 3) showed single band for positive sera, conﬁrming a speciﬁc reaction. On the other hand ELISA neg-
ative sera showed no visible band in Western blot analysis.4. Discussion
SOD has been identiﬁed in a great variety of organisms and it has been subject of multiple studies, as a candidate for a che-
motherapeutic target, in particular in those pathogens such as protist parasites which possess an Fe-SOD not present in human
and/or animals (Wilson et al., 1994; Meshnick and Eaton, 1981). Fe-SOD excreted by different species of Leishmania has been al-
ready studied as well. Sera from patients affected by L. peruviana, Leishmania amazonensis and L. braziliensis (with proven identi-
ﬁcation of the agents) had been tested with the Fe-SOD excreted by these Leishmania species and then the results had been
compared for speciﬁcity evaluation of the antigen (Marín et al., 2009). Recently the Fe-SOD excreted by L. infantum has been pu-
riﬁed and tested as antigens in the diagnosis of visceral canine leishmaniasis. Puriﬁed enzyme proved to be more sensitive than
the non-puriﬁed one, eliminating all false positive or negative results, using samples from positive, negative and unknown-status
dogs (Longoni et al., 2013). The Fe-SOD excreted by L. amazonensis and L. peruviana has also been puriﬁed and used as antigens in
human leishmaniasis diagnosis (Longoni et al., 2014), conﬁrming its high speciﬁcity eliminating all kind of cross reaction that the
not puriﬁed antigen was producing (Longoni et al., 2014).
Many studies have been conducted to discover a speciﬁc antigen for Leishmania with the aim to increase the speciﬁcity of the
serodiagnostic. Most of them focus on visceral leishmaniasis; only few antigens have been studied for cutaneous leishmaniasis.
Currently, only the rk39 antigen for L. infantum is accepted and recommended by the WHO (2010). Nowadays there is no sero-
logical assay available to detect an infection due by L. braziliensis. Okumura et al. (2014) reported a serological identiﬁcation of
L. braziliensis, among others species of Leishmania at the same time, using a not puriﬁed pool of antigens from promastigotes of
different Leishmania spp.; it has already well demonstrated that the not puriﬁed pool of antigens from whole promastigotes are
not species speciﬁc inducing false results, both positive or negative, indeed it cannot be considered as a reliable antigen (Marín
et al., 2009). In the present study, using the puriﬁed Fe-SOD excreted by L. braziliensis as an antigen, we tested 213 human
sera from Mexico in ELISA and Western blot techniques. The serum samples used in this study were from patients who tested
negative in parasitological examinations and had no dermal lesions at the time of the blood taking. Thus, these patients were
not having an active infection but they could have had an infection in the past, which would be revealed in a positive serological
test.
In the present study using non-puriﬁed Fe-SODe as the antigen, we found around 10% false outcome compared to the results
obtained with the puriﬁed protein. Using the puriﬁed Fe-SODe as antigen, we found 17.84% positive and complete correspondence
between the two techniques, ELISA and Western blot, as observed previously using L. infantum Fe-SODe puriﬁed (Longoni et al.,
2013). As it has been demonstrate by our previous works using positive control sera, the puriﬁed protein, excreted by L. infantum
(Longoni et al., 2013) and by L. peruviana and L. amazonensis (Longoni et al., 2014), is much more sensitive than the non-puriﬁed
one. Based on these results we are conﬁdent with the results here obtained and the difference between puriﬁed and non-puriﬁed
proteins is explained by the elimination of all impurities present in the non-puriﬁed antigen that generate false reaction, positive
or negative, as WHO afﬁrms (WHO, 2010). Although the enzyme is reliable, the results were somewhat surprising, thus a further
conﬁrmation of those results is given when the sera were separated according to the State from where they were. In Nuevo Leon
State 26.51% of the sera were positive to the Fe-SODe-Lb meanwhile only 3.70% of sera from Hidalgo State were positive. If we
focus our attention on the geography of these Mexican States we can observe that Nuevo Leon is bordering Texas where some
cases of weird non-self healing and very resistant to treatment lesions in patients have been reported (Maloney et al., 2002;
McHugh et al., 1996) which brought clinicians to suspect a L. braziliensis infection (Petersen, 2009), whereas the State of Hidalgo
is far from those areas where L. braziliensis has been reported. Mexico–US border is one of the biggest borders worldwide. In those
areas where they share vertebrate and invertebrate vectors, where the migration is massive and where the health policies are not
the same (Esteve-Gassent et al., 2014) it should not be surprising that there are reported cases of possible L. braziliensis infection
from US and not from the Mexican areas, despite the wake-up call to Mexican health authorities in 2001 by Sanchez-Tejeda et al.
(2001).
Summarizing, in the present work we made an important forward step in Leishmania diagnostic. We have conﬁrmed the high
sensitivity of the puriﬁed Fe-SODe, demonstrating for the ﬁrst time that it is possible to use 200-fold less amount (0.05 μg/well)
compared with the amount used when applying the complete pool of proteins obtained from promastigote culture (Marín et al.,
2009) which is still currently used for serodiagnosis (Okumura et al., 2014) and even 13-fold less amount of puriﬁed protein com-
pared with the results previously published by our group (Longoni et al., 2013; 2014). Despite the technique used to purify the
protein is quite expensive this paper would open the door to massive generation of a recombinant antigen which will decrease
considerably the cost of the assay. Moreover the use of the puriﬁed protein shows also 100% correspondence between the two
techniques used: ELISA and Western blot, being the second more sensitive but also more expensive and usually not affordable
in endemic countries. Second but not less important, we have surprisingly described for the ﬁrst time the presence of
L. braziliensis antibodies in human populations from the central and northern Mexico that could reveal a possible focus of infection
for L. braziliensis in that area in future.
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